For CLTI patients with infrapopliteal artery disease, everolimus-eluting scaffold was found to be superior to angioplasty.

Published Date: 08 Nov 2023

In comparison to angioplasty, everolimus-eluting resorbable scaffold treatment produces better results for chronic conditions, according to a multi-institution study headed by the Prince of Wales Hospital and University of New South Wales, Australia.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.

2.

Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.

3.

Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.

4.

AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer

5.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot